Bioanalytical method development and validation are at the forefront of ensuring rigorous, reproducible and reliable data in both drug development and clinical diagnostics. The field encompasses the ...
Anyone relying on the particle size results from DLS or liquid particle counters should consider and address how the data will be used and how to assure the quality of the final results. This ...
Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.
Deep-Transfer-Learning–Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic Cancer The first approach led to a ...
The US Food and Drug Administration (FDA) has released a final guidance document with immediate effect advising sponsors on ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
This suite automates the commissioning, qualification, and validation (CQV) of processes, equipment, and systems. It includes three AI-enabled applications: Together, these systems work in tandem to ...
The FDA Process Validation training highlights opportunities in enhancing comprehension of constant process verification aligned with lifecycle concepts. It addresses early R&D phases through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results